[Testosterone treatment of renal anemia. Evaluation of success by means of morphometric bone marrow and erythrocyte volume determinations].
D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood; D000536:Aluminum Hydroxide / Q000627:therapeutic use; D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D001663:Bilirubin / Q000097:blood; D001856:Bone Marrow Examination; D002860:Chromium Radioisotopes; D004906:Erythrocyte Count; D004921:Erythropoietin / Q000096:biosynthesis; D005260:Female; D006400:Hematocrit; D006454:Hemoglobins; D006801:Humans; D007501:Iron / Q000097:blood / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000150:complications; D008297:Male; D008875:Middle Aged; D009392:Nephrectomy; D006435:Renal Dialysis / Q000009:adverse effects; D013739:Testosterone / Q000627:therapeutic use*; D000637:Transaminases / Q000097:blood; D014815:Vitamins / Q000627:therapeutic use; D014831:Voice
D002860:Chromium Radioisotopes; D006454:Hemoglobins; D014815:Vitamins; D004921:Erythropoietin; D013739:Testosterone; D000536:Aluminum Hydroxide; D007501:Iron; D000637:Transaminases; D000469:Alkaline Phosphatase; D001663:Bilirubin
Testosteronbehandlung renaler Anämie. Erfolgsbeurteilung anhand morphometrischer Knochenmark- und Erythrozytenvolumenbestimmungen